11 IPOs Scheduled for the Week of March 17

Francis Gaskins |

The full IPO calendar is available at IPOpremium.  Scheduled IPOs are ranked by IPO size.

(1) Based in San Jose, CA, A10 Networks (ATEN) scheduled a $175 million IPO on the NYSE with a market capitalization of $826 million at a price range midpoint of $14 for Friday, March 21, 2014.

ATEN’s solutions enable enterprises, service providers, Web giants and government organizations to accelerate, secure and optimize the performance of their data center applications and networks.

(2) Based in Fort Worth, TX, TPG Specialty Lending (TSLX) scheduled a $116 million IPO on the NYSE with a market capitalization of $855 million at a price range midpoint of $16.50 for Friday, March 21, 2014.

TSLX is a specialty finance BDCfocused on lending to middle-market companies.

(3) Based in Austin, TX, Q2 Holdings (QTWO) scheduled a $93 million IPO on the NYSE with a market capitalization of $383 million at a price range midpoint of $12 for Thursday, March 20, 2014.

QTWO is a leading provider of secure, cloud-based, Software as a Service (SaaS) virtual banking solutions.

(4) Based in Redwood City, CA, Versartis (VSAR) scheduled a $81 million IPO on the Nasdaq with a market capitalization of $383 million at a price range midpoint of $17.50 for Friday, March 21, 2014.

VSAR is an endocrine-focused biopharmaceutical company initially developing its novel long-acting recombinant human growth hormone, VRS-317, for growth hormone deficiency, or GHD, an orphan disease.

(5) Based in Cambridge, MA, Akebia Therapeutics (AKBA) scheduled a $76 million IPO on the Nasdaq with a market capitalization of $283 million at a price range midpoint of $15.50 for Thursday, March 20, 2014.

AKBA is a biopharmaceutical company focused on the development of novel proprietary therapeutics based on hypoxia inducible factor, or HIF, biology and the commercialization of these products for patients with kidney disease.



(6) Based in East Rutherford, NJ, Amber Road (AMBR) scheduled a $75 million IPO on the NYSE with a market capitalization of $286 million at a price range midpoint of $11.50 for Friday, March 21, 2014.

AMBR automates import and export processes to enable goods to flow across international borders in the most efficient, compliant and profitable way.

(7) Based in New York, NY, Borderfree (BRDR) scheduled a $75 million IPO on the Nasdaq with a market capitalization of $457 million at a price range midpoint of $15 for Friday, March 21, 2014.

BRDR is a global ecommerce platform for online retailers.

(8) Based in Dublin, Ireland, Globoforce (THNX) scheduled a $75 million IPO on the Nasdaq with a market capitalization of $457 million at a price range midpoint of $17 for Friday, March 21, 2014.

THNX offers gift cards and other options through a global e-commerce rewards network.

(9) Based in Yavne, Israel, MediWound (MDWD) scheduled a $75 million IPO on the Nasdaq with a market capitalization of $306 million at a price range midpoint of $15 for Thursday, March 20, 2014.

MDWD is a fully integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel products to address unmet needs in the fields of severe burns, chronic and hard-to-heal wounds and connective tissue disorders.

(10) Based in Arlington Heights, IL, Paylocity (PCTY) scheduled a $100 million IPO on the Nasdaq with a market capitalization of $734 million at a price range midpoint of $15 for Wednesday, March 19, 2014.

PCTY is a cloud-based provider of payroll and HCM software solutions for medium-sized organizations, which PCTY defines as those having between 20 and 1,000 employees.

(11) Based in Santa Rosa, CA,  Ruthigen (RTGN) scheduled an $18.5 million IPO at a price range mid-point of $8.25, with a fully diluted market capitalization (assuming all warrants are converted) of $73 million for Wednesday March 19, 2014.

RTGN is a re-cycled IPO originally scheduled for November, 2013, with different underwriters

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
ATEN A10 Networks Inc. 8.10 -1.45 -15.18 2,195,392 Trade
TSLX TPG Specialty Lending Inc. 20.91 0.06 0.29 162,045 Trade
QTWO Q2 Holdings Inc. 38.15 -0.15 -0.39 230,439 Trade
AKBA Akebia Therapeutics Inc. 13.18 -0.05 -0.38 2,482,892 Trade
MDWD MediWound Ltd. 6.00 -0.30 -4.76 46,458 Trade
VSAR Versartis Inc. 18.40 -1.40 -7.07 618,698 Trade
RTGN RTGN n/a n/a n/a 0 Trade
PCTY Paylocity Holding Corporation 39.44 -0.26 -0.65 111,429 Trade
AMBR Amber Road Inc. 8.19 -0.06 -0.73 109,188 Trade
CNNCF Cnnc International Ltd Or n/a n/a n/a 0

Comments

Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

D-Wave

D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…